Notice2024-12277
Agency Information Collection Activities; Submission for OMB Review; Comment Request; Authorization Request Form and Certification/Letter of Medical Necessity for Compounded Drugs (OWCP-26)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 5, 2024
Issuing agencies
Labor Department
Abstract
The Department of Labor (DOL) is submitting this Office of Workers' Compensation Programs (OWCP)-sponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 109 (Wednesday, June 5, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 109 (Wednesday, June 5, 2024)]
[Notices]
[Pages 48193-48194]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-12277]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF LABOR
Agency Information Collection Activities; Submission for OMB
Review; Comment Request; Authorization Request Form and Certification/
Letter of Medical Necessity for Compounded Drugs (OWCP-26)
ACTION: Notice of availability; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Department of Labor (DOL) is submitting this Office of
Workers' Compensation Programs (OWCP)-sponsored information collection
request (ICR) to the Office of Management and Budget (OMB) for review
and approval in accordance with the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are invited.
DATES: The OMB will consider all written comments that the agency
receives on or before July 5, 2024.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: Michelle Neary by telephone at 202-
693-6312, or by email at <a href="/cdn-cgi/l/email-protection#bffbf0f3e0efedfee0efeafdf3f6fcffdbd0d391d8d0c9"><span class="__cf_email__" data-cfemail="9cd8d3d0c3ccceddc3ccc9ded0d5dfdcf8f3f0b2fbf3ea">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: OWCP will require the claimant's treating
physician to complete a Form OWCP-26 online before payment will be made
for a compounded drug. The physician will be required to specify the
ingredients in the compounded drug, indicate whether the compounded
drug and each of its ingredients are medically necessary, and explain
why the claimant cannot use an FDA-approved drug instead of the
compounded drug being prescribed. The form will permit the OWCP to more
easily track the volume, type, and characteristics of compounded drugs
prescribed for claimants. It will allow additional oversight of the
pharmacy benefit--improving patient safety, decreasing cost for
stakeholders, and decreasing the risk for fraud, waste, and abuse.
Completed forms will be reviewed by a clinical pharmacist or physician
before being reviewed for decision by the individual program staff. For
additional substantive information about this ICR, see the related
notice published in the Federal Register on March 26, 2024 (89 FR
21015).
Comments are invited on: (1) whether the collection of information
is necessary for the proper performance of the functions of the
Department, including whether the information will have practical
utility; (2) if the information will be processed and used in a timely
manner; (3) the accuracy of the agency's estimates of the burden and
[[Page 48194]]
cost of the collection of information, including the validity of the
methodology and assumptions used; (4) ways to enhance the quality,
utility and clarity of the information collection; and (5) ways to
minimize the burden of the collection of information on those who are
to respond, including the use of automated collection techniques or
other forms of information technology.
This information collection is subject to the PRA. A Federal agency
generally cannot conduct or sponsor a collection of information, and
the public is generally not required to respond to an information
collection, unless the OMB approves it and displays a currently valid
OMB Control Number. In addition, notwithstanding any other provisions
of law, no person shall generally be subject to penalty for failing to
comply with a collection of information that does not display a valid
OMB Control Number. See 5 CFR 1320.5(a) and 1320.6.
DOL seeks PRA authorization for this information collection for
three (3) years. OMB authorization for an ICR cannot be for more than
three (3) years without renewal. The DOL notes that information
collection requirements submitted to the OMB for existing ICRs receive
a month-to-month extension while they undergo review.
Agency: DOL-OWCP.
Title of Collection: Authorization Request Form and Certification/
Letter of Medical Necessity for Compounded Drugs (OWCP-26).
OMB Control Number: 1240-0NEW.
Affected Public: Private Sector--Businesses or other for-profits.
Total Estimated Number of Respondents: 78.
Total Estimated Number of Responses: 490.
Total Estimated Annual Time Burden: 245 hours.
Total Estimated Annual Other Costs Burden: $0.
(Authority: 44 U.S.C. 3507(a)(1)(D))
Michelle Neary,
Senior Paperwork Reduction Act Analyst.
[FR Doc. 2024-12277 Filed 6-4-24; 8:45 am]
BILLING CODE 4510-CR-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 5, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.